23.75k followers • 14 symbols Watchlist by TREA
Follow this list to discover and track the stock of publicly traded companies with COVID-19 related treatment and healthcare plans.
Curated by TREA
Watchlist | Change today | 1-month return | 1-year return | Total return |
---|---|---|---|---|
The fight against COVID19 | -0.29% | - | - | - |
^GSPC | -0.23% | -1.29% | +18.20% | +4545.23% |
Symbol | Company name | Last price | Change | % change | Market time | Volume | Avg vol (3-month) | Market cap |
---|---|---|---|---|---|---|---|---|
JNJ | Johnson & Johnson | 160.5 | -1.16 | -0.72% | 4:00 pm GMT-4 | 4.95M | 22.93M | 386.49B |
ABBV | AbbVie Inc. | 152.74 | -0.69 | -0.45% | 4:00 pm GMT-4 | 3.03M | 4.93M | 269.59B |
PFE | Pfizer Inc. | 32.69 | -0.16 | -0.49% | 4:01 pm GMT-4 | 23.68M | 24.81M | 184.57B |
SNY | Sanofi | 54.02 | -0.26 | -0.48% | 4:00 pm GMT-4 | 889.31k | 1.23M | 138.33B |
GILD | Gilead Sciences, Inc. | 75.01 | -0.26 | -0.35% | 4:00 pm GMT-4 | 4.35M | 5.55M | 93.46B |
REGN | Regeneron Pharmaceuticals, Inc. | 824.84 | +1.46 | +0.18% | 4:00 pm GMT-4 | 310.97k | 596.08k | 89.54B |
GSK | GSK plc | 37.43 | -0.19 | -0.51% | 4:00 pm GMT-4 | 3.83M | 3.33M | 77.47B |
TAK | Takeda Pharmaceutical Company Limited | 15.84 | -0.09 | -0.56% | 4:00 pm GMT-4 | 1.33M | 2.13M | 49.52B |
MRNA | Moderna, Inc. | 99.99 | -0.24 | -0.24% | 4:00 pm GMT-4 | 2.23M | 3.86M | 38.06B |
BNTX | BioNTech SE | 104.64 | -1.79 | -1.68% | 4:00 pm GMT-4 | 470.56k | 678.64k | 25.09B |
VIR | Vir Biotechnology, Inc. | 9.35 | +0.21 | +2.30% | 4:00 pm GMT-4 | 2.26M | 1.53M | 1.26B |
NVAX | Novavax, Inc. | 7.13 | +0.32 | +4.70% | 4:00 pm GMT-4 | 6.44M | 9.04M | 719.45M |
INO | Inovio Pharmaceuticals, Inc. | 0.3938 | +0.01 | +1.86% | 4:00 pm GMT-4 | 2.91M | 3.87M | 105.57M |
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...
With its stock down 12% over the past month, it is easy to disregard BioNTech (NASDAQ:BNTX). However, a closer look at...
Key Insights Regeneron Pharmaceuticals' estimated fair value is US$1,376 based on 2 Stage Free Cash Flow to Equity...